20th Anniversary
Membership
- Current Members
Initiatives
Advocacy
About
RBQM Summary Report

Signant Health White Paper: Strategies for Continued IRT Success During COVID-19

June 2, 2020 By Natalia Gonzalez

Previous Article

Food and Drug Administration Guidance: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention

Next Article

ICON Factsheet: Integrated Solution Keeping your trial on track during COVID-19

Recent Posts

ACRO Announces 2023 Officers and New Member
ACRO Expands Decentralized Clinical Trials Toolkit with Release of Change Management Resource
ACRO & TransCelerate Issue a Joint Statement on Considerations while Developing Clinical Study Reports (CSRs)
ACRO Releases Diversity and Inclusion Principles Statement in Support of More Diverse Clinical Trials
OPINION: Keep Our Foot on the Gas for Clinical Trial Diversity

About ACRO

The Association of Clinical Research Organizations (ACRO) and its members collaborate in pursuit of a global regulatory and business environment that fosters efficient, effective & safe clinical research.

Subscribe

Get in Touch

601 New Jersey Ave NW, #350,
Washington DC 20001
info@acrohealth.org
+1 (202) 464-9340

© ACRO 2021